Early versus late chest radiotherapy in patients with limited-stage small cell lung cancer

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 12, 2004, Pages

  Pijls Johannesma, Madelon ^a   De Ruysscher, Dirk K M ^a   Lambin, Philippe ^a   Houben, Ruud ^a   Rutten, Isabelle ^b   Vansteenkiste, Johan F ^c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84871040125     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004700.pub2     Document Type: Review

References (30)

1. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. Journal of Clinical Oncology 1997;15(3):893-900.
2. Murray N, Coy P, Pater JL, Hodson I, Arnold A, Zee BC, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology 1993;11(2):336-44.
3. Perry MC, Herndon JE, Eaton WL, Green MR. Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B Study 8083. Journal of Clinical Oncology 1998;16(7):2466-7.
4. Skarlos DV, Samantas E, Briassoulis E, Panoussaki E, Pavlidis N, Kalofonos HP, et al. Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG). Annals of Oncology 2001;12(9):1231-8.
5. Spiro S, James LE, Rudd RM, Trask C, Tobias JS, Snee M, et al. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized trial and meta-analysis. Journal of Clinical Oncology 2006;24(24):3823-30.
6. Takada M, Fukuoka M, Kawahara M, Sugiura T, Yokoyama A, Yokota S, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. Journal of Clinical Oncology 2002;20(14):3054-60.
7. Work E, Nielsen OS, Bentzen SM, Fode K, Palshof T. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group. Journal of Clinical Oncology 1997;15(9):3030-7.
8. Blackstock AW, Bogart JA, Matthews C, Lovato JF, McCoy T, Livengood K, et al. Split-course versus continuous thoracic radiation therapy for limited-stage small-cell lung cancer: final report of a randomized phase III trial. Clinical Lung Cancer 2005;6(5):287-92.
9. Bonner JA, Sloan JA, Shanahan TG, Brooks BJ, Marks RS, Krook JE, et al. Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma. Journal of Clinical Oncology 1999;17(9):2681-91.
10. Gregor A, Drings P, Burghouts J, Postmus PE, Morgan D, Sahmoud T, et al. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study. Journal of Clinical Oncology 1997;15(8):2840-9.
11. Lebeau B, Urban T, Brechot JM, Paillotin D, Vincent J, Leclerc P, et al. A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. Cancer 1999;86(8):1480-7.
12. Turrisi AT, Kim K, Blum R, Sause WT, Livingston RB, Komaki R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. New England Journal of Medicine 1999;340(4):265-71.
13. Auperin A, Arriagada R, Pignon JP, Le Pechoux C, Gregor A, Stephens RJ, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. New England Journal of Medicine 1999;341(7):476-84.
14. Bentzen SM, Thomas HD. Clinical evidence for tumor clonogen regeneration: interpretations of the data. Radiotherapy and Oncology 1991;22:161-6.
15. Bunn PA Jr, Carney DN. Overview of chemotherapy for small cell lung cancer. Seminars in Oncology 1997;24(2 Suppl 7):69S-74S.
16. Davis AJ, Tannock IF. Repopulation of tumor cells between cycles of chemotherapy: a neglected factor. The Lancet Oncology 2000;1:86-93.
17. De Ruysscher D, Vansteenkiste J. Chest radiotherapy in limited-stage small cell lung cancer: facts, questions, prospects. Radiotherapy and Oncology 2000;55(1):1-9.
18. De Ruysscher D, Pijls-Johannesma M, Bentzen SM, Minken A, Wanders R, Lutgens L, et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. Journal of Clinical Oncology 2006;24(7):1057-63.
19. Harari PM, Mehta MP, Ritter MA, Petereit DG. Clinical promise tempered by reality in the delivery of combined chemoradiation for common solid tumors. Seminars in Radiation Oncology 2003;13(1):3-12. [MEDLINE: 20030109]
20. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
21. Ihde DC. Small cell lung cancer. State-of-the-art therapy 1994. Chest 1995;107(6 Suppl):243S-248S.
22. Kelly K. New chemotherapy agents for small cell lung cancer. Chest 2000;117(4 Suppl 1):156S-162S.
23. Kumar P. The role of thoracic radiotherapy in the management of limited-stage small cell lung cancer: past, present, and future. Chest 1997;112(4 Suppl):259S-65S.
24. Pignon JP, Arriagada R, Ihde DC, Johnson DH, Perry MC, Souhami RL, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. New England Journal of Medicine 1992;327(23):1618-24.
25. Pijls-Johannesma M, De Ruysscher DK M, Lambin P, Rutten I, Vansteenkiste JF. Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials. Cancer Treatment Reviews 2007;33(5):461-73.
26. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8(16):1-16.
27. Turrisi AT, Sherman CA. The treatment of limited small cell lung cancer: a report of the progress made and future prospects. European Journal of Cancer 2002;38(2):279-91.
28. Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. Journal of Clinical Oncology 1992;10(6):890-5.
29. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncologica (Stockholm, Sweden) 1988;27:131-46.
30. Pijls-Johannesma M, De Ruysscher DKM, Lambin P, Rutten I, Vansteenkiste JF. Early versus late chest radiotherapy in patients with limited stage small cell lung cancer. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD004700.pub2]